141 related articles for article (PubMed ID: 38176716)
1. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma.
Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT
J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716
[TBL] [Abstract][Full Text] [Related]
2.
Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
[TBL] [Abstract][Full Text] [Related]
3. Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N
Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1194-1203. PubMed ID: 33890170
[TBL] [Abstract][Full Text] [Related]
4. High quality imaging and dosimetry for yttrium-90 (
Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
6. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
7. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
Soydal C; Kucuk ON; Bilgic S; Ibis E
Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716
[TBL] [Abstract][Full Text] [Related]
8. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O
Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
[TBL] [Abstract][Full Text] [Related]
10. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
11. Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres.
Depalo T; Traino AC; Bargellini I; Lorenzoni G; Bozzi E; Vivaldi C; Lamastra R; Masi G; Cioni R; Boni G; Volterrani D
Sci Rep; 2021 Oct; 11(1):19745. PubMed ID: 34611210
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
Haug AR; Heinemann V; Bruns CJ; Hoffmann R; Jakobs T; Bartenstein P; Hacker M
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1037-45. PubMed ID: 21308371
[TBL] [Abstract][Full Text] [Related]
13. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
Yu Q; Patel M; Kwak D; Ungchusri E; Wang Y; Van Ha T; Zangan S; Marshall E; Little K; Baker T; Liao CY; Pillai A; Ahmed O
J Vasc Interv Radiol; 2023 Nov; 34(11):1970-1976.e1. PubMed ID: 37532096
[TBL] [Abstract][Full Text] [Related]
14. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A
Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442
[TBL] [Abstract][Full Text] [Related]
15. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
[TBL] [Abstract][Full Text] [Related]
16. Radioembolization with
Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
[TBL] [Abstract][Full Text] [Related]
17. A deep-learning-based prediction model for the biodistribution of
Plachouris D; Tzolas I; Gatos I; Papadimitroulas P; Spyridonidis T; Apostolopoulos D; Papathanasiou N; Visvikis D; Plachouri KM; Hazle JD; Kagadis GC
Med Phys; 2021 Nov; 48(11):7427-7438. PubMed ID: 34628667
[TBL] [Abstract][Full Text] [Related]
18.
Tabotta F; Gnesin S; Dunet V; Ponti A; Digklia A; Boughdad S; Schaefer N; Prior JO; Villard N; Tsoumakidou G; Denys A; Duran R
Sci Rep; 2023 Aug; 13(1):13118. PubMed ID: 37573346
[TBL] [Abstract][Full Text] [Related]
19. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
[TBL] [Abstract][Full Text] [Related]
20. Dose-Response and Dose-Toxicity Relationships for Glass
Alsultan AA; van Roekel C; Barentsz MW; Smits MLJ; Kunnen B; Koopman M; Braat AJAT; Bruijnen RCG; de Keizer B; Lam MGEH
J Nucl Med; 2021 Nov; 62(11):1616-1623. PubMed ID: 33741643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
